logo
Did Baby Talk Give Rise to Language?

Did Baby Talk Give Rise to Language?

New York Times25-06-2025
If you've ever cooed at a baby, you have participated in a very special experience. Indeed, it's an all but unique one: Whereas humans constantly chatter to their infants, other apes hardly ever do so, a new study reveals.
'It's a new feature that has evolved and massively expanded in our species,' said Johanna Schick, a linguist at the University of Zurich and an author of the study. And that expansion, Dr. Schick and her colleagues argue, may have been crucial to the evolution of language.
Other mammals can bark, meow, roar and hoot. But no other species can use a set of sounds to produce words, nor build sentences with those words to convey an infinite variety of meaning. To trace the origin of our gift of language, researchers often study apes, our closest living relatives.
These studies hint that some of the ingredients of language had already evolved in the ancestors we share with living apes, which lived millions of years ago. Chimpanzees can make dozens of distinct calls, for example, which they can join into pairs to communicate new things. Building meaning from smaller units is what lets us create sentences from words.
Humans and apes are similar in another way: Their babies need time to learn how to make sounds like adults. Scientists have done much more research into how human infants develop language than into how wild baby apes learn to make calls. One striking feature of humans is the way that adults speak to young children. Baby talk — known to scientists as infant-directed speech — often features repeated words, an exaggerated stress on syllables and a high, singsong tone.
This distinctive pattern is very effective at grabbing the attention of young children — even when they're too young to understand the meaning of the words that adults are saying. It's possible that children pay attention to infant-directed speech because it helps them learn some of the basic features of language.
Want all of The Times? Subscribe.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

āshibio licences vantictumab for rare bone disorder
āshibio licences vantictumab for rare bone disorder

Yahoo

time3 minutes ago

  • Yahoo

āshibio licences vantictumab for rare bone disorder

Biotechnology company āshibio has entered an exclusive licencing agreement with Mereo BioPharma for the monoclonal antibody, vantictumab, to treat a rare bone disorder. The agreement aims to facilitate antibody development for the autosomal dominant osteopetrosis type 2 (ADO2) bone condition that currently lacks approved therapies. āshibio will oversee clinical development of vantictumab globally for both adult and paediatric patients. Mereo has granted exclusive rights to āshibio for the development and commercialisation in the US and other regions outside of Europe, where Mereo retains commercial rights. ADO2, also referred to as Albers-Schönberg disease, is a genetic disorder characterised by reduced osteoclast function, leading to dense and brittle bones. It is linked to mutations in the chloride channel 7 (CLCN7) gene, with an incidence rate of one in 20,000 births. Āshibio CEO Pankaj Bhargava stated: 'People living with autosomal dominant osteopetrosis type 2 face a lifetime of bone-related complications resulting in significant morbidity, multiple surgical procedures, chronic pain and impaired quality of life – yet patients have no approved therapy to address the disease. 'Bringing vantictumab into our pipeline reflects our commitment to advancing therapies for rare skeletal conditions and improving the lives of those affected by serious bone disorders.' Vantictumab functions by selectively binding to specific frizzled (Fzd) receptors and inhibiting Wnt (wingless-related integration) signalling pathways. Initially developed for cancer treatment, it has undergone clinical trials in oncology showing a favourable safety and pharmacokinetic profile. Previous studies have generated biomarker data that support the efficacy of vantictumab on osteoclast function, which aids in reducing risks associated with the clinical programme and allows āshibio to expedite the advancement of vantictumab into clinical trials for ADO2. "āshibio licences vantictumab for rare bone disorder" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.

Serbian scientists experiment with mealworms to degrade polystyrene
Serbian scientists experiment with mealworms to degrade polystyrene

Yahoo

time3 minutes ago

  • Yahoo

Serbian scientists experiment with mealworms to degrade polystyrene

Serbian scientists experiment with mealworms to degrade polystyrene BELGRADE (Reuters) -Serbian scientists have been experimenting with mealworms as a way to break down polystyrene. Larisa Ilijin, a principal research fellow at Belgrade's Institute for Biology, said the scientists had discovered that mealworms can digest various plastics, including polystyrene, which is used in packaging, insulation and food containers. In the project endorsed by the government and the United Nations' agency for international development, UNDP, and other international donors, they have been including the polystyrene in the regular food of the larval form of the yellow mealworm beetle, or Tenebrio molitor. They habitually eat more or less anything, but need the training to eat the plastic products. "We have larvae that have been adapted over a long time to biodegrade plastic, to be as efficient as possible in the process," Ilijin told Reuters. She said the bacteria living in their guts break down the plastic into carbon dioxide and water, and showed no evidence of leaving microplastic residue in their innards or faeces. The work builds on similar research projects in the U.S. and Africa. Serbia, which hopes to join the EU, recycles only 15% of municipal waste, far below the EU's 55% target and less than 2% of household waste. Over 84% of waste ends up in about 3,000 landfill sites, often unregulated and filled with plastic, cardboard, paper and organic waste. It is looking for ways to meet EU waste treatment standards. "Styrofoam takes over 500 years to decompose in nature ... this would be one of the good ways for solving the problem of plastic waste in nature," Ilijin said. The institute has given Belgrade-based Belinda Animals several containers of the mealworms. It is now breeding them and hoping to attract a network of similar farms. 'When breaking down 1 kg of Styrofoam, larvae emit one to two grams of carbon dioxide ... If we incinerate it ... (Styrofoam) emits over 4,000 times more,' owner Boris Vasiljev said. He also envisages the larvae being used as animal feed, should it reach a large commercial scale. The use of mealworms is still in its infancy, Ilijin said, as Serbia still needs to adopt regulations that would allow the use and sale of insect products for animal fodder. Solve the daily Crossword

Lab Equipment Market and Supply Chain Forecasts 2025-2030 Featuring Eppendorf, Beckman Coulter, Agilent Technologies, Thermo Fisher Scientific, Waters Corp. & More
Lab Equipment Market and Supply Chain Forecasts 2025-2030 Featuring Eppendorf, Beckman Coulter, Agilent Technologies, Thermo Fisher Scientific, Waters Corp. & More

Yahoo

time33 minutes ago

  • Yahoo

Lab Equipment Market and Supply Chain Forecasts 2025-2030 Featuring Eppendorf, Beckman Coulter, Agilent Technologies, Thermo Fisher Scientific, Waters Corp. & More

The Lab Equipment Market is projected to grow at 7% CAGR, driven by increased pharmaceutical R&D, rising chronic disease prevalence, and growing demand for biologics Lab Equipment Market Dublin, Aug. 20, 2025 (GLOBE NEWSWIRE) -- The "Lab Equipment Market - Forecasts from 2025 to 2030" has been added to offering. The global lab equipment market foresees significant expansion, projected to grow from USD 19.507 billion in 2025 to USD 27.310 billion by 2030, registering a CAGR of 6.96%. This growth trajectory is underpinned by dynamic factors, anticipated to propel the market. Pharmaceutical R&D investments are a primary catalyst, with global spending reaching USD 280 billion in 2024, focusing on groundbreaking drugs and biologics. Streamlined clinical trial processes, exemplified by the European Medicines Agency's fast-track schemes reducing approval times, emphasize the demand for cutting-edge lab equipment essential for drug discovery. Chronic disease prevalence, including cancer, diabetes, and cardiovascular conditions, further accelerates market demand. In 2024, the U.S. recorded 1.9 million new cancer cases, underlining the urgency for advanced diagnostics and drug development. The rising chronic disease burden globally, particularly in aging populations, intensifies the need for sophisticated lab tools. Biologics, derived from living organisms, represent a rapidly growing market segment, accounting for a substantial portion of the pharmaceutical pipeline in 2024. With 40% of clinical trials targeting biologics, specialized lab equipment becomes indispensable for development and testing, driving market expansion. Segment-wise, the sensing equipment category, including spectrometers and conductivity meters, dominates due to its pivotal role in precise diagnostics and drug development. Biopharmaceutical companies hold the largest market share, bolstered by substantial R&D budgets and specialized equipment requirements. Government and academic institutions also contribute significantly, with increased public funding for health research. Geographically, North America leads with over 35% of global lab equipment revenue, supported by advanced healthcare infrastructure. Meanwhile, Asia-Pacific emerges as the fastest-growing region, buoyed by a rising incidence of chronic diseases and increased pharmaceutical investments. Europe's growth is reinforced by regulatory backing for innovative therapies. Key industry players, including Eppendorf AG and Thermo Fisher Scientific Inc., dominate due to robust brand reputations and innovative product offerings. For instance, in 2023, Thermo Fisher launched advanced spectrometry equipment for biologics research, enhancing precision and driving market leadership. Nevertheless, the market faces challenges such as high costs of advanced equipment and the requisite skilled personnel for operating complex systems. Regulatory requirements often delay market entry, necessitating continuous innovation to meet compliance standards. This report provides: Market insights spanning major and emerging regions, focusing on consumer tendencies and industry verticals. Understanding of strategies employed by global key players. Exploration of market drivers and future trends. Actionable insights for strategic business decisions. Catering to startups, research institutions, SMEs, and large enterprises. Report Highlights: Historical data (2022-2024) and forecast (2025-2030). Analysis of growth opportunities, challenges, and regional trends. Strategies and market share analysis of leading companies. Revenue growth projections by segments and regions. Company profiling, strategic developments, and product information. Lab Equipment Market Segmentation: By Type: Analytical Instruments, General Lab Equipment, Measuring & Monitoring Devices, Specialty Equipment, Support Equipment. By End-User: Academic & Research Institutes, Biopharmaceutical & Pharmaceutical Companies, Healthcare & Diagnostic Labs, Government & Regulatory Bodies, Industrial & Manufacturing, Others. By Geography: North America, South America, Europe, Middle East and Africa, Asia-Pacific. Key Attributes Report Attribute Details No. of Pages 150 Forecast Period 2025-2030 Estimated Market Value (USD) in 2025 $19.51 Billion Forecasted Market Value (USD) by 2030 $27.31 Billion Compound Annual Growth Rate 6.9% Regions Covered Global Key Topics Covered1. EXECUTIVE SUMMARY2. MARKET SNAPSHOT2.1. Market Overview2.2. Market Definition2.3. Scope of the Study2.4. Market Segmentation3. BUSINESS LANDSCAPE3.1. Market Drivers3.2. Market Restraints3.3. Market Opportunities3.4. Porter's Five Forces Analysis3.5. Industry Value Chain Analysis3.6. Policies and Regulations3.7. Strategic Recommendations4. TECHNOLOGICAL OUTLOOK5. GLOBAL LAB EQUIPMENT MARKET BY TYPE5.1. Introduction5.2. Analytical Instruments5.3. General Lab Equipment5.4. Measuring & Monitoring Devices5.5. Specialty Equipment5.6. Support Equipment6. GLOBAL LAB EQUIPMENT MARKET BY END-USER6.1. Introduction6.2. Academic & Research Institutes6.3. Biopharmaceutical & Pharmaceutical Companies6.4. Healthcare & Diagnostic Labs6.5. Government & Regulatory Bodies6.6. Industrial & Manufacturing6.7. Others7. GLOBAL LAB EQUIPMENT MARKET BY GEOGRAPHY7.1. Introduction7.2. North America7.3. South America7.4. Europe7.5. Middle East and Africa7.6. Asia-Pacific8. COMPETITIVE ENVIRONMENT AND ANALYSIS8.1. Major Players and Strategy Analysis8.2. Market Share Analysis8.3. Mergers, Acquisitions, Agreements, and Collaborations8.4. Competitive Dashboard9. COMPANY PROFILES9.1. Eppendorf AG9.2. Beckman Coulter, Inc.9.3. Agilent Technologies, Inc.9.4. Thermo Fisher Scientific Inc.9.5. Waters Corporation9.6. F. Hoffmann-La Roche Ltd9.7. Shimadzu Corporation9.8. Bio-Rad Laboratories, Inc.9.9. PerkinElmer Inc.10. APPENDIX For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Lab Equipment Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store